lup-20(29)-en-3-ol | 107596-77-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: lup-20(29)-en-3-ol
• 英文别名: 20(29)-lupen-3-ol；lupeol；lup-20(29)-en-3β-ol；lupenol；(1R,3aR,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol
• CAS: 107596-77-0
• 化学式: C₃₀H₅₀O
• 分子量: 426.726
• InChiKey: MQYXUWHLBZFQQO-UPIGTVCGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.9
• 重原子数：
  31
• 可旋转键数：
  1
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  lup-20(29)-en-3-ol 在 pyridinium chlorochromate 作用下， 以 二氯甲烷 为溶剂， 生成 羽扇烯酮
  参考文献：
  名称：

  Roy, Kamal; Raj; Bhaduri, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1998, vol. 37, # 8, p. 774 - 777

  摘要：

  DOI：
• 作为产物：
  描述：

  lup-20(29)-en-3-ol acetate 在 氢氧化钾 作用下， 以20 mg的产率得到lup-20(29)-en-3-ol
  参考文献：
  名称：

  一种新的来自灰绿紫薇的三萜。

  摘要：

  从VERNONIA CINEREA的根源上少。（菊科）一种新的三萜类化合物已经被分离出来，并被表征为3beta-acetoxyurs-19-ene（1）。已经鉴定出另一种成分为乙酸鲁贝醇。在光谱分析的帮助下进行了结构阐明。

  DOI：

  10.1055/s-2006-959732

文献信息

• PHOTOCATALYST-FREE, LIGHT-INDUCED CARBON-SULFUR CROSS-COUPLING METHODS
  申请人：THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE

  公开号：US20180370911A1

  公开（公告）日：2018-12-27

  In one aspect, the invention provides a method of promoting a carbon-sulfur bond forming reaction. In certain embodiments, the reaction comprises cross-coupling of a(n) (hetero)aryl halide with a thiol to form the carbon-sulfur bond, wherein the method is promoted by light irradiation in the absence of a photocatalyst. In other embodiments, the cross-coupling reaction can be promoted through visible light irradiation, including sunlight.

  在某个方面，该发明提供了一种促进碳硫键形成反应的方法。在某些实施例中，该反应包括(hetero)aryl卤化物与硫醇的交叉偶联，形成碳硫键，其中该方法在没有光催化剂的情况下通过光照促进。在其他实施例中，交叉偶联反应可以通过可见光照射来促进，包括阳光。
• FORMULATIONS FOR THE DELIVERY OF ACTIVE AGENTS TO INSECTS, PLANTS, AND PLANT PATHOGENS
  申请人：Preceres Inc.

  公开号：US20170325457A1

  公开（公告）日：2017-11-16

  The present disclosure is directed to formulations comprising (1) at least one formulation transport agent, (2) at least one complexing agent, and (3) at least one active agent that modulates one or more traits of a target insect, plant, or plant pathogen. The present disclosure is also directed to methods of delivering such formulations to the target organism, as well as to formulation transport agents used to prepare such formulations.

  本公开涉及包含（1）至少一种制剂运输剂、（2）至少一种络合剂和（3）至少一种调节目标昆虫、植物或植物病原体的一个或多个特征的活性剂的配方。本公开还涉及将这种配方传递给目标生物体的方法，以及用于制备这种配方的制剂运输剂。
• CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS
  申请人：ReSet Therapeutics, Inc.

  公开号：US20150284362A1

  公开（公告）日：2015-10-08

  The subject matter herein is directed to carbazole-containing amide, carbamate, and urea derivatives and pharmaceutically acceptable salts or hydrates thereof of structural formula I wherein the variable R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , A, D, E, G, J, L, M, Q, a, and b are accordingly described. Also provided are pharmaceutical compositions containing the compounds of formula I to treat a Cry-mediated disease or disorder, such as diabetes, complications associated with diabetes, Cushing's syndrome, NASH, NAFLD, asthma, and COPD.

  本文涉及含有咔唑基的酰胺、碳酸酯和脲衍生物，以及其结构式I中的药用可接受盐或水合物，其中变量R1、R2、R3、R4、R5、R6、R7、A、D、E、G、J、L、M、Q、a和b分别描述。还提供了含有式I化合物的药物组合物，用于治疗Cry介导的疾病或紊乱，如糖尿病、与糖尿病相关的并发症、库欣综合征、NASH、NAFLD、哮喘和COPD。
• [EN] PRODRUGS OF 4'-C-SUBSTITUTED-2-HALO-2'-DEOXYADENOSINE NUCLEOSIDES AND METHODS OF MAKING AND USING THE SAME<br/>[FR] PROMÉDICAMENTS DE NUCLÉOSIDES DE 4'-C-SUBSTITUÉ-2-HALO-2'-DÉSOXYADÉNOSINE ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：GILEAD SCIENCES INC

  公开号：WO2021188959A1

  公开（公告）日：2021-09-23

  The present disclosure provides prodrugs of 4'-C-substituted-2- halo-2'-deoxyadenoside nucleosides, and compositions, methods and kits thereof. Such compounds can be useful for treating viral infections including, human immunodeficiency virus. The compounds have the following formula (I).

  本公开提供了4'-C-取代-2-卤-2'-脱氧腺苷核苷的前药，以及其组合物、方法和试剂盒。这些化合物可用于治疗包括人类免疫缺陷病毒在内的病毒感染。这些化合物具有以下化学式（I）。
• TRITERPENES DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS OR ANTI-INFLAMMATORY AGENTS
  申请人：PICHETTE ANDRE

  公开号：US20080167254A1

  公开（公告）日：2008-07-10

  A compound of formula (1): wherein R 1 is selected from the group consisting of H, α-L-Rhamnopyranose, α-D-Mannopyranose, β-D-Xylopyranose, β-D-Glucopyranose, and α-D-Arabinopyranose; R 2 is selected from CH 3 , COOH, CH 2 OH, COOCH 3 and CH 2 O-α-D-Arabinopyranose; with the proviso that the compound of formula (I) is not a compound of formula (I) wherein R 1 is β-D-Glucopyranose and R 2 is COOH; wherein R 1 is α-L-Rhamnopyranose and R 2 is CH 3 ; wherein R 1 is β-D-Glucopyranose and R 2 is CH 2 OH; wherein R 1 is β-D-Xylopyranose and R 2 is CH 2 OH; wherein R 1 is α-L-Rhamnopyranose and R 2 is COOCH 3 , wherein R 1 is H and R 2 is CH 3 ; wherein R 1 is H and R 2 is CH 2 OH; wherein R 1 is H and R 2 is COOH; or wherein R 1 is H and R 2 is COOCH 3 , or a pharmaceutically acceptable salt thereof.

  式（1）的化合物：其中R1选自H、α-L-葡萄糖苷、α-D-甘露糖苷、β-D-木糖苷、β-D-葡萄糖苷和α-D-阿拉伯糖苷组成的群；R2选自CH3、COOH、CH2OH、COOCH3和CH2O-α-D-阿拉伯糖苷；但化合物的式（I）不是式（I）中R1为β-D-葡萄糖苷且R2为COOH的化合物；其中R1为α-L-葡萄糖苷且R2为CH3；其中R1为β-D-葡萄糖苷且R2为CH2OH；其中R1为β-D-木糖苷且R2为CH2OH；其中R1为α-L-葡萄糖苷且R2为COOCH3；其中R1为H且R2为CH3；其中R1为H且R2为CH2OH；其中R1为H且R2为COOH；或其中R1为H且R2为COOCH3，或其药学上可接受的盐。